Could a poop pill help teens with anorexia?
NCT ID NCT06593366
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether fecal microbiota transplant (FMT) – taking capsules made from healthy donor stool – is a feasible and acceptable treatment for 20 teens (ages 12-17) with anorexia nervosa. Participants will take FMT or placebo capsules twice a day, twice a week for 8 weeks. The study will measure recruitment, retention, and changes in weight, gut bacteria, and mood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fecal microbiota transplant (FMT) from healthy donors
What this could lead to
If it works, this could point toward a new way to help teens with anorexia gain weight and feel better by restoring gut health.
What could go wrong
This is a very small pilot study (20 teens) testing only feasibility, not effectiveness. It may not show clear benefits, and the long-term safety of FMT in this group is unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANOREXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••